Long Term Follow up of Water Vapor Thermal Therapy (Rezum) for Benign Prostatic Hyperplasia (BPH)

Long Term Post-operative Effectiveness and Morbidity of Rezum Therapy for Benign Prostatic Hyperplasia

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT05982444

Enrollment

Registered

2023-08-08

Start date

2021-03-01

Completion date

2025-05-01

Last updated

2025-06-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Benign Prostatic Hyperplasia, Lower Urinary Track Symptoms

Keywords

water vapor thermal therapy

Brief summary

This study aims to assess the effectiveness and morbidity of water vapor thermal therapy (Rezūm therapy) for benign prostatic hyperplasia (BPH). Data will be collected and analyzed from patients treated by Rezūm and followed up for 4 years prior to evaluating clinical outcomes.

Detailed description

The investigators will conduct a retrospective study evaluating patients treated with water vapor thermal therapy (Rezūm therapy) for BPH and followed up for4 years. The primary objectives are to assess the long-term effectiveness and morbidity rates associated with the procedure. Data collected will include urinary symptom scores, sexual function, and any treatment-related complications.

Interventions

PROCEDUREwater vapor thermal therapy (Rezum) for prostate

all patients underwent rezum therapy for bph are evaluated for its effectiveness for long period

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

MALE

Age

40 Years to 80 Years

Healthy volunteers

Inclusion criteria

* patients underwent rezum procedure for benign prostatic hyperplasia from 2 to 4 years

Exclusion criteria

* previous prostatic intervention * concurrent urological morbidity like urethral stricture * neurological disease like parkinson's disease

Design outcomes

Primary

Measure	Time frame	Description
change in prostate volume	4 years	Prostate volume will be measured via transrectal ultrasound.
hange in International Prostate Symptom Score (IPSS)	4 years	IPSS is a questionnaire evaluating urinary symptoms. Scores ranging from 0 to 7 indicate mild symptoms, from 8 to 19 moderate symptoms, and from 20 to 35 severe symptoms.
international index of erectile function (IIEF)	4 years	IIEF is a questionnaire evaluating sexual function. Scores ranging from 5 to 7 indicate severe symptoms, 8 to 11 moderate symptoms, 12 to 16 mild to moderate symptoms, 17 to 21 mild symptoms, and 22 to 25 no erectile dysfunction
Change in Post-Void Residual Urine	4 years	Residual urine volume measured after urination using pelvic ultrasound.

Secondary

Measure	Time frame	Description
Retreatment Rate Following Rezūm Therapy	4 years	Number of participants requiring additional treatment for BPH after Rezūm therapy.
complication rate	4 years	incidence of complications post procedure during follow-up

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026